New insights in atherosclerosis research: LOX-1, leading actor of cardiovascular diseases;Nuovi approfondimenti nella ricerca su l'ateroslerosi: LOX-1, un primo attore nelle malattie cardiovascolari

Clinica Terapeutica

Volumn 158, Issue 3, 2007, Pages 239-248

  Novelli, Giuseppe ^a,c,d   Mango, R ^a   Vecchione, L ^a   Mariotti, E ^b   Borgiani, P ^a   Mehta, J L ^c   Romeo, F ^a,c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b SAN SALVATORE HOSPITAL   (Italy)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

Author keywords

Apoptosis; Association studies; Atherosclerosis; Complex diseases; LOX 1; LOXIN; Myocardial infarction; ox LDL; Polymorphisms

Indexed keywords

ANGIOTENSIN II; CYTOKINE; ENDOTHELIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; ENDOTHELIUM INJURY; GENETIC POLYMORPHISM; HEART INFARCTION; NONHUMAN; REVIEW; SHEAR STRESS;

AMINO ACID OXIDOREDUCTASES; ANIMALS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; HUMANS;

EID: 34250724859     PISSN: 00099074     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. Chilton RJ. Pathophysiology of coronary heart disease: a brief review. J Am Osteopath Assoc 2004; 104:S5-8
2. Lusis AJ. Atherosclerosis. Nature 2000; 407:233-41
3. Dhaliwal BS, Steinbrecher UP. Scavenger receptors and oxidized low density lipoproteins. Clin Chim Acta 1999; 286:191-205
4. Bickel PE, Freeman M. Rabbit aortic smooth muscle cells express inducible macrophage scavenger receptor messenger RNA that is absent from endothelial cells. J Clin Invest 1992; 90:1450-7
5. Sawamura T, Kume N, Aoyama T, et al. An endothelial receptor for oxidized low-density lipoprotein. Nature 1997; 386:73-7
6. Mehta JL, Li DY. Identification and autoregulation of receptor for Ox-LDL in cultured human coronary artery endothelial cells. Biochem Biophys Res Commun 1998; 248:511-4
7. Li DY, Sawamura T, Mehta JL. Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type-1 receptor activation. Circ Res 1999; 84:1043-9
8. Chen M, Kakutani M, Naruko T. Activation-dependent surface expression of LOX-1 in human platelets. Biochem Biophys Res Commun 2001; 282:153-8
9. Kataoka H, Kume N, Miyamoto S. Oxidized LDL modulates Bax/Bcl-2 through the lectin-like Ox-LDL receptor-1 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2001; 21:955-60
10. Yoshida H, Kondratenko N, Green S. Identification of the lectin-like receptor of oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor. Biochem J 1998; 334:9-13
11. Chen K, Chen J, Liu Yong, et al. Expression of adhesion molecules in fibroblasts: alteration in fibroblast biology following transfection with LOX-1 plasmids. Hypertension (in press)
12. Chen M, Kakutani M, Minami M. Increased expression of lectin-like oxidized low density lipoprotein receptor-1 in initial atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb Vasc Biol 2000; 20:1107-15
13. Nagase M, Hirose S, Sawamura T, et al. Enhanced expression of endothelial oxidized low-density lipoprotein receptor (LOX-1) in hypertensive rats. Biochem Biophys Res Commun 1997; 237:496-8
14. Chen J, Li D, Schaefer R, Mehta JL. Cross-talk between dyslipidemia and renin-angiotensin system and the role of LOX-1 and MAPK in atherogenesis: studies with the combined use of rosuvastatin and candesartan. Atherosclerosis (in press)
15. Li D, Chen H, Staples ED, et al. Oxidized low-density lipoprotein receptor LOX-1 and apoptosis in human atherosclerotic lesions. J Cardiovasc Pharmacol Ther 2002; 7:147-53
16. Li D, Mehta JL. Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors. Arterioscler Thromb Vasc Biol 2000; 20:1116-22
17. Li D, Mehta JL. Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells. Circulation 2000; 101:2889-95
18. Kume N, Sawamura T, Moriwaki H, et al. Inducible expression of LOX-1, a novel lectin-like receptor for oxidized low density lipoprotein, in vascular endothelial cells. Circ Res 1998; 83:322-7
19. Murase T, Kume N, Korenaga R, et al. Fluid shear stress transcriptionally induces lectin-like oxidized LDL receptor-1 in vascular endothelial cells. Circ Res 1998; 83:328-33
20. Kataoka H, Miyamoto S. Expression of lectin-like oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation 1999; 99:3110-7
21. Chen M, Nagase M, Fujita T, et al. Diabetes enhances lectin-like oxidized LDL receptor-1 (LOX-1) expression in the vascular endothelium: possible role of LOX-1 ligand and age. Biochem Biophys Res Commun 2001; 87:962-8
22. Aoyama T, Sawamura T, Furutani Y, et al. Structure and chromosomal assignment of the human lectin-like oxidized low-density-lipoprotein receptor-1 (LOX-1) gene. Biochem J 1999; 39:177-84
23. Yamanaka S, Zhang XY, Miura K, et al. The human gene encoding the lectin-type oxidized LDL receptor (OLR1) is a novel member of the natural killer gene complex with a unique expression profile. Genomics 1998; 54:191-9
24. Chen J, Liu Y, Liu H, et al. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) transcriptional regulation by Oct-1 in human endothelial cells: implications for atherosclerosis. Biochem J 2006; 393(Pt 1):255-65
25. Chen M, Masaki T, Sawamura T. LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis. Pharmacol Ther 2002; 95:89-100
26. Chen M, Inoue K, Narumiya S, et al. Requirements of basic amino acid residues within the lectin-like domain of LOX-1 for the binding of oxidized low-density lipoprotein. FEBS Lett 2001; 499:215-9
27. Chen M, Sawamura T. Essential role of cytoplasmic sequences for cell-surface sorting of the lectin-like oxidized LDL receptor-1 (LOX-1). J Mol Cell Cardiol (in press)
28. Xie Q, Matsunaga S, Shi X, Ogawa S, et al. Refolding and characterization of the functional ligand-binding domain of human lectin-like oxidized LDL receptor. Protein Expr Purif 2003; 32:68-74
29. Chen M, Narumiya S, Masaki T, et al. Conserved C-terminal residues within the lectin-like domain of LOX-1 are essential for oxidized low-density- lipoprotein binding. Biochem J 2001; 355:289-96
30. Ohki I, Ishigaki T, Oyama T, et al. Crystal structure of human lectin-like, oxidized low-density lipoprotein receptor 1 ligand binding domain and its ligand recognition mode to OxLDL. Structure 2005; 13:905-17
31. Park H, Adsit FG, Boyington JC. The 1.4 anstrom crystal structure of the human oxidized low density lipoprotein receptor lox-1. J Biol Chem 2005; 280:13593-9
32. Marsche G, Levak-Frank S, Quehenberger O, et al. Identification of the human analog of SR-BI and LOX-1 as receptors for hypochlorite-modified high density lipoprotein on human umbilical venous endothelial cells. FASEB J 2001; 15:1095-7
33. Moriwaki H, Kume N, Sawamura T, et al. Ligand specificity of LOX-1, a novel endothelial receptor for oxidized low density lipoprotein. Arterioscler Thromb Vasc Biol 1998; 18:1541-7
34. Oka K, Sawamura T, Kikuta K, et al. Lectin-like oxidized low-density lipoprotein receptor 1 mediates phagocytosis of ged/apoptotic cells in endothelial cells. Proc Natl Acad Sci USA 1998; 95:9535-40
35. Kakutani M, Masaki T, Sawamura T. A platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1. Proc Natl Acad Sci USA 2000; 97:360-4
36. Shimaoka T, Kume N, Minami M, et al. LOX-1 supports adhesion of Gram-positive and Gram-negative bacteria. Immunol 2001; 166:5108-14
37. Murphy JE, Tacon D, Tedbury PR, et al. LOX-1 scavenger receptor mediates calcium-dependent recognition of phosphatidylserine and apoptotic cells. Biochem J 2006; 393(Pt 1):107-15
38. Nagase M, Ando K, Nagase T, et al. Redox-sensitive regulation of lox-1 gene expression in vascular endothelium. Biochem Biophys Res Commun 2001; 281:720-5
39. Kita T, Kume N, Ishii K, et al. Oxidized LDL and expression of monocyte adhesion molecules. Diabetes Res Clin Pract 1999; 45:123-6
40. Li L, Sawamura T, Renier G. Glucose enhances human macrophage LOX-1 expression: role for LOX-1 in glucose-induced macrophage foam cell formation. Circ Res 2004; 94:892-901
41. Chen H, Li D, Sawamura T, et al. Upregulation of LOX-1 expression in aorta of hypercholesterolemic rabbits: modulation by losartan. Biochem Biophys Res Commun 2000; 276:1100-4
42. Chen J, Li D, Schaefer RF, Mehta JL. Inhibitory effect of candesartan and rosuvastatin on CD40 and MMPs expression in apo-E knockout mice: novel insights into the role of RAS and dyslipidemia in atherogenesis. J Cardiovasc Pharmacol 2004; 44:446-52
43. Muscoli C, Sacco I, Alecce W, et al. The protective effect of superoxide dismutase mimetic M40401 on balloon injury-related neointima formation: role of the lectin-like oxidized low-density lipoprotein receptor-1. J Pharmacol Exp Ther 2004; 311:44-50
44. Hayashida K, Kume N, Minami M, et al. Peroxisome proliferator-activated receptor alpha ligands activate transcription of lectin-like oxidized low density lipoprotein receptor-1 gene through GC box motif. Biochem Biophys Res Commun 2004; 323:1116-23
45. Chiba Y, Ogita T, Ando K, et al. PPARgamma ligands inhibit TNF-alpha-indueed LOX-1 expression in cultured endothelial cells. Biochem Biophys Res Commun 2001; 286:541-6
46. Mehta JL, Hu B, Chen J, et al. Pioglitazone inhibits LOX-1 expression in human coronary artery endothelial cells by reducing intracellular superoxide radical generation. Arterioscler Thromb Vasc Biol 2003; 23:2203-8
47. Mehta JL, Chen J, Yu F, et al. Aspirin inhibits ox-LDL-mediated LOX-1 expression and metalloproteinase-1 in human coronary endothelial cells. Cardiovasc Res 2004; 64:243-9
48. Li D, Singh RM, Liu L, et al. Oxidized-LDL through LOX-1 increases the expression of angiotensin converting enzyme in human coronary artery endothelial cells. Cardiovasc Res 2003; 57:238-43
49. Li D, Liu L, Chen H, et al. LOX-1, an oxidized LDL endothelial receptor, induces CD40/CD40L signaling in human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol 2003; 23:816-21
50. Li D, Chen H, Mehta JL. Statins inhibit oxidized-LDL-mediated LOX-1 expression, uptake of oxidized-LDL and reduction in PKB phosphorylation. Cardiovasc Res 2001; 52:130-5
51. Li D, Mehta JL. Ox-LDL induces apoptosis in human coronary artery endothelial cells: role of PKC, PTK, bcl-2, and Fas. Am J Physiol 1998; 275:H568-76
52. Li D, Chen H, Sawamura T, et al. Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells: role of LOX-1. J Pharmacol Exp Ther 2002; 302:601-5
53. Erl W, Weber PC, Weber C. Monocytic cell adhesion to endothelial cells stimulated by oxidized low-density lipoprotein is mediated by distinct endothelial ligands. Atherosclerosis 1998; 136:297-303
54. Li D, Liu L, Chen H, et al. LOX-1 mediates oxidized low-density lipoprotein-induced expression of matrix metalloproteinases in human coronary artery endothelial cells. Circulation 2003; 107:612-7
55. Cominacini L, Pasini AF, Garbin U, et al. Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J Biol Chem 2000; 275:12633-8
56. Chavakis E, Dernbach E, Dimmeler S. Oxidized LDL inhibits vascular endothelial growth factor-induced endothelial cell migration by an inhibitory effect on the Akt/endothelial nitric oxide synthase pathway. Circulation 2001; 103:2102-7
57. Chen J, Mehta JL, Haider N, et al. Role of caspases in Ox-LDL-induced apoptotic cascade in human coronary artery endothelial cells. Circ Res 2004; 94:370-6
58. Kume N: Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J Clin Invest 1994; 93:907-11
59. Draude G, Lorenz RL. The expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) on human vascular smooth muscle cells and monocytes and its down-regulation by lovastatin. Biochem Pharmacol 1999; 57:383-6
60. Hamakawa Y, Omori N, Nagase M, et al. Severity dependent up-regulations of LOX-1 and MCP-1 in early sclerotic changes of common carotid arteries in spontaneously hypertensive rats. Neurol Res 2004; 26:767-73
61. Morawietz H, Rueckschloss U, Niemann B, et al. Angiotensin II induces LOX-1, the human endothelial receptor for oxidized low-density lipoprotein. Circulation 1999; 100:899-902
62. Conti CR, Mehta JL. Acute myocardial ischemia: role of atherosclerosis, thrombosis, platelet activation, coronary vasospasm, and altered arachidonic acid metabolism. Circulation 1987; 75:84-95
63. Chen LY, Mehta P, Mehta JL. Oxidized LDL decreases L-arginine uptake and nitric oxide synthase protein expression in human platelets: relevance of the effect of oxidized LDL on platelet function. Circulation 1996; 93:1740-6
64. Mehta JL, Li D. Identification, regulation and function of a novel lectin-like oxidized low-density lipoprotein receptor. J Am Coll Cardiol 2002; 39:1429-35
65. Ehara S, Ueda M, Naruko T, et al. Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation 2001; 103:1955-60
66. Harrison GJ, Jordan LR, Selley ML, et al. Low-density lipoproteins inhibit histamine and NaNO2 relaxations of the coronary vasculature and reduce contractile function in isolated rat hearts. Heart Vessels 1995; 10:249-57
67. Li D, Williams V, Liu L, et al. Expression of lectin-like oxidized low-density lipoprotein receptors during ischemia-reperfusion and its role in determination of apoptosis and left ventricular dysfunction. J Am Coll C-ardiol 2003; 41:1048-55
68. Chui PC, Guan HP, Lehrke M, et al. PPARgamma regulates adipocyte cholesterol metabolism via oxidized LDL receptor 1. J Clin Invest 2005;115:2244-56
69. Maingrette F, Renier G. Linoleic endothelial cells.acid increases lectin-like oxidized LDL receptor-1 (LOX-1) expression in human aortic. Diabetes 2005; 54(5):1506-13
70. Honjo M, Nakamura K, Yamashiro K, et al. Lectin-like oxidized LDL receptor-1 is a cell-adhesion molecule involved in endotoxin-induced inflammation. Proc Natl Acad Sci USA 2003; 100:1274-9
71. Jeannin P, Bottazzi B, Sironi M, et al. Complexity and complementarity of outer membrane protein A recognition by cellular and humoral innate immunity receptors. Immunity 2005; 22:551-60
72. Chen H, Li D, Saldeen T, et al. Transforming growth factor-beta(1) modulates oxidatively modified LDL-induced expression of adhesion molecules: role of LOX-1. Circ Res 2001; 89:1155-60
73. Hofnagel O, Luechtenborg B, Stolle K, et al. Proinflammatory cytokines regulate LOX-1 expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2004; 24:1789-95
74. Tatsuguchi M, Furutani M, Hinagata J, et al. Oxidized LDL receptor gene (OLR1) is associated with the risk of myocardial infarction. Biochem Biophys Res Commun 2003; 303:247-50
75. Chen Q, Reis SE, Kammerer C, et al. Genetic variation in lectin-like oxidized low-density lipoprotein receptor 1 (LOX1) gene and the risk of coronary artery disease. Circulation 2003; 107:3146-51
76. Mango R, Clementi F, Borgiani P, et al. Association of single nucleotide polymorphisms in the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction. J Med Genet 2003; 40:933-6
77. Mango R, Biocca S, Del Vecchio F, et al. In vivo and in vitro studies support that a new splicing isoform of olr1 gene is protective against acute myocardial infarction. Circ Res 2005; 97(2):152-8.Epub 2005 Jun 23
78. Fuster V, Stein B, Ambrose JA, et al. Atherosclerotic plaque rupture and thrombosis. Evolving concepts. Circulation 1990; 82 (3 Suppl): II47-59
79. Libby P. Inflammation in atherosclerosis. Nature 2002; 420:868-74
80. Murase T, Kume N, Kataoka H, et al. Identification of soluble forms of lectin-like oxidized LDL receptor-1. Arterioscler Thromb Vasc Biol 2000; 20:715-20
81. Hayashida K, Kume N, Murase T, et al. Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome: a novel marker for early diagnosis. Circulation 2005; 112:812-8